Cavtat-Dubrovnik, Croatia
More info
News & events
Innate Pharma announces its turnover for the first quarter of 2010 and updates on its cash situation
May 5, 2010
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces a turnover of 0.1 million euros (105 thousand euros) for the first quarter of 2010, compared with 2.5 million euros (2,488 thousand euros) for the same period in 2009.
Innate Pharma announces the release of its annual report and reference document (in French)
April 29, 2010
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces that the French version of the 2009 Reference Document, including the Annual Financial Report, as well as the 2009 Annual Report of the Company, is available on its website.
Innate Pharma to hold its Annual General Meeting of Shareholders on May 25, 2010, in Marseilles, France
April 21, 2010
Innate Pharma (Euronext Paris: FR0010331421 – IPH) will hold its Annual General Meeting of Shareholders (“AGM”) on May 25, 2010, at 10 am in its headquarters, 117 avenue de Luminy, F-13009 Marseille.
Number of shares outstanding and voting rights, as of March 31, 2010
April 8, 2010
Innate Pharma SA has released the total number of shares outstanding and voting rights, as of March 31, 2010
Innate Pharma updates on it next meetings with analysts and investors
April 7, 2010
Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its participation to the following analyst and investor conferences in the coming weeks:
Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009 and updates on its drug candidates
March 5, 2010
Progress of clinical portfolio and strenghtnening of cash position.
Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009.
Unaudited consolidated financial statements are attached to this press release.